Você esta aqui:Home > Therapeutics (antigo) > Marijuana Use in HIV-Positive and AIDS Patients: Results of an Anonymous Mail Survey

J Cannabis Ther 2001(3/4):035-41

Survey

Marijuana Use in HIV-Positive and AIDS Patients: Results of an Anonymous Mail Survey

Author
S. Sidney

Abstract
While there is a great deal of anecdotal reporting regarding the medical use of marijuana in HIV-positive patients, there have been few systematic surveys performed. The prevalence of medical use of marijuana in HIV-positive and AIDS patients was assessed by an anonymous mail survey of 1970 attendees of HIV clinics in the San Francisco, Oakland, and South Sacramento medical centers of the Kaiser Permanente Medical Care Program (KPMCP) in California. Of 442 responders (22.4% response rate), 147 (33.3%) reported current use of marijuana for medical purposes. Among current users, the most common reasons for using cannabis were: to feel better mentally/reduce stress (79%), improve appetite/gain weight (67%) and decrease nausea (66%). Patterns of use were heterogeneous, with daily use of cannabis reported by 34% of current users. Nearly half of participants reported buyers' clubs as a source for obtaining cannabis, a finding of particular interest because of recent successful government efforts in closing down these clubs in California. In combination with other reported surveys, these data suggest that the use of marijuana for medical purposes is relatively common in HIV-positive and AIDS patients.


Keywords
Marijuana, cannabis, HIV, AIDS, epidemiology

PDF do texto completo ]

Free Online Events 2020

You can find all information here.

The IACM is holding a free webinar series and a free anniversary online meeting from October to November 2020

All webinars will be held in English with subtitles in German, French, Spanish, and Portuguese. All webinars will be available online until March 2021

The anniversary online meeting to celebrate the IACM's 20th anniversary and to honour the 90th birthday of Raphael Mechoulam will be a live session only on the 5th November 2020.

The speakers in the webinar series are Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli, and Ethan Russo.

You can find all information here.

Conferência 2021

A 12ª Conferência da IACM sobre Canabinoides em Medicina será realizada em Basileia, Suíça, de 14 a 16 de Outubro de 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.